31722-313-10 : NDC 2026 Code

31722-313-10 : Cisatracurium Besylate ( Cisatracurium Besylate )

Additionally :

You can get information about “31722-313-10” NDC code in 31722-313-10 in HTML format

HTML | 31722-313-10 in TXT (Plain Text) format

TXT | 31722-313-10 in PDF (Portable Document Format)

PDF | 31722-313-10 in XML format

XML formats.

NDC Code : 31722-313-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "31722-313-10",
    "PackageDescription": "10 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10)  / 5 mL in 1 VIAL, SINGLE-DOSE (31722-313-02) ",
    "NDC11Code": "31722-0313-10",
    "ProductNDC": "31722-313",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cisatracurium Besylate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cisatracurium Besylate",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20260504",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212432",
    "LabelerName": "Camber Pharmaceuticals Inc.",
    "SubstanceName": "CISATRACURIUM BESYLATE",
    "StrengthNumber": "2",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-05-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260504",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}